Sky News: Could interstitial fluid replace blood?
UC graduate discusses new frontier of health monitoring
Sky News highlighted University of Cincinnati research into the next frontier of continuous health monitoring.
UC College of Engineering and Applied Science graduate Mark Friedel developed a prototype sensor that monitors chemicals found in the interstitial fluid just under your skin. The sensor uses tiny microneedles that pick up information about your health that can be tracked over time.
UC biomedical engineering graduate Mark Friedel and his research collaborators developed wearable technology in UC professor Jason Heikenfeld's Novel Devices Lab. Photo/Andrew Higley/UC Marketing + Brand
He co-authored a study looking at the potential for interstitial fluid in continuous health monitoring that was published in the journal Nature Biomedical Engineering.
Interstitial fluid contains many of the same chemicals and biomarkers that doctors use in blood to diagnose disease or track health and wellness, Friedel told Local 12.
Friedel developed the sensor in UC professor Jason Heikenfeld's Novel Devices Lab.
“Why we see it as a valuable diagnostic fluid is continuous access. With blood, you can’t easily take continuous readings,” Friedel said.
Featured image at top: UC's Mantei Center is a cornerstone of the College of Engineering and Applied Science. Photo/Andrew Higley/UC Marketing + Brand
More UC biomedical engineering in the news
University of Cincinnati biomedical engineers say sensors that monitor interstitial fluid could be the next frontier for wearable technology. Photo/Mark Friedel
- National Science Foundation: Getting under your skin for better health
- Technology Networks: Advantages and challenges of using interstitial fluid in diagnostics
- Laboratory Equipment: Interstitial fluid could better monitor health
UC College of Engineering and Applied Science professor Jason Heikenfeld and his students develop wearable technology in his Novel Devices Lab. Photo/Andrew Higley/UC Marketing + Brand
Related Stories
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.
National inventors group recognizes UC provost
December 11, 2025
The National Academy of Inventors on Thursday named the interim provost of the University of Cincinnati to its 2025 class of fellows.
Celebrating the newest Bearcats on Decision Day
December 11, 2025
The University of Cincinnati admits its newest Bearcats for Fall 2026. Interest in the university is at an all-time high with more than 35,000 applicants for admission. Decision Day was also a time to celebrate 10 new Marian Spencer Scholarship recipients.